Community Oncology Setting Disease Outcomes of Sorafenib (Nexavar) Use in Advanced Renal Cell Carcinoma

Clinical trial NCT00876382 · COMPLETED

Trial details

NCT number: NCT00876382
Sponsor: SCRI Development Innovations, LLC
Status: COMPLETED
Study type: OBSERVATIONAL

Renal Cell Carcinoma

Start date: 2009-05-01
Primary completion: 2011-02-01
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.